KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
ITR Premium, United Kingdom - 16 March 2012
China piloted a new VAT regime in Shanghai in January. It now plans to expand the programme to Beijing on July 1 ... Read the full article
Related links
RSS feeds